論文・総説

  • 1998年

    • Li, T., Narhi, L.O., Wen, J., Philo, J.S., Sitney, K., Inoue, J., Yamamoto, T. and Arakawa, T. 
      Interactions between NFκB and its inhibitor IκB: Biophysical characterization of a NFκB/IκBα complex. 
      J. Protein Chem. 17, 757-763. (1998)
    • Yoshimoto, T., Nagase, H., Yoneto, T., Inoue, J. and Nariuchi, H. 
      Interleukin-12 expression in B cells by transformation with Epstein-Barr virus. 
      Biochem. Biophy. Res. Commun. 252, 556-560. (1998)
    • Kittaka, A., Kuze, T., Asakura, T., Ito, K., Miyasaka, T., and Inoue, J. 
      Oligonucleotides bearing 5-formyl-2'-O-methyluridine: Selective binding affinity to the NF-κB (p50)2 homo-amd p50/p65 heterodimers. 
      Bioorg. Med. Chem. Lett. 8, 3207-3210. (1998)
    • Suginaka, R., Izui, R., Inoue, J., Muraoka, Y., Yamaguchi, K., Otsuka, M., and Umezawa, K. 
      Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand. 
      Jpn. J. Cancer Res. 89, 947-953. (1998)
    • Kimura, H., Inukai, Y., Takii, T., Furutani, Y., Shibata, Y., Hayashi, H., Sakurada, S., Okamoto, T., Inoue, J., Oomoto, Y. and Onozaki, K. 
      Molecular analysis of constitutive IL-1α gene expression in human melanoma cells: Autocrine stimulation through NF-κB activation by endogenous IL-1α. 
      Cytokine 10, 872-879. (1998)
    • Kashiwada, M., Shirakata, Y., Inoue, J., Nakano, H., Okazaki, K., Okumura, K., Yamamoto, T., Nagaoka, H and Takemori, T. 
      Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD signaling along Ras-independent pathway. 
      J. Exp. Med. 187, 237-244. (1998)
    • Suzuki, K., Tsuchida, J., Yamamoto, T. and Inoue, J. 
      Identification and expression of the Xenopus homolog of mammalian p100-NFκB2.
      Gene 206, 1-9. (1998)
    • Mizushima, S., Fujita, M., Ishida, T., Azuma, S., Kato, K., Hirai, M., Otsuka, M., Yamamoto, T. and Inoue, J. 
      Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5). 
      Gene 207, 135-140. (1998)
    • Horie, R., Aizawa, S., Nagai, M., Ito, K., Ishida, T., Inoue, J. and Watanabe, T. 
      A novel domain in the CD30 cytoplasmic tail mediates NFκB activation. 
      Int. Immunol. 10, 203-210. (1998)
    • Hogan, M and Akiyama, T. 
      "Triple helix strategies and progress" in Antisense Research and Application: Handbook of Experimental Pharmacology, S. T. Crooke, ed., Springer-Verlag, Heidelberg, vol 131, pp. 561-530 (1998).